Associate Professor, Medicine, Duke University School of Medicine
Oncology
Dr. Neal E. Ready, MD
|
|
Give Review
Dr. Neal E. Ready is an expert in the field of Oncology. He studied medicine at Vanderbilt University School of Medicine. He has 3 awards "America's Top Doctors", "CMS Meaningful Use Stage 1 Certification" and "America's Top Doctors for Cancer". Neal Ready is also a published doctor. He has 49 paper published. The most recent paper is: Post transfusion non-cardiogenic pulmonary edema in a patient with chemotherapy-related hemolytic uremic syndrome. Neal Ready accepts Medicare payments and is registered with Medicare.gov.
Publications
- Phase 1 Dose Escalation Study of Accelerated Radiation Therapy With Concurrent Chemotherapy for Locally Advanced Lung Cancer.
- Chemotherapy With or Without Maintenance Sunitinib for Untreated Extensive-Stage Small-Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase II Study-...
- Accuracy of positron emission tomography in identifying hilar (N1) lymph node involvement in non-small cell lung Cancer: Implications for stereotactic body radiation t...
- Smoking history predicts for increased risk of second primary lung Cancer: A comprehensive analysis.
- Tumor Acquisition for Biomarker Research in Lung Cancer.
- Prognostic Validation of the Body Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity (BODE) Index in Inoperable Non-Small-Cell Lung Cancer.
- Stereotactic radiotherapy for malignancies involving the trigeminal and facial nerves.
- Cisplatin, Irinotecan, and Bevacizumab for Untreated Extensive-Stage Small-Cell Lung Cancer: CALGB 30306, a Phase II Study.
- Pathologic response after neoadjuvant carboplatin and weekly paclitaxel for early-stage lung Cancer: a Brown University oncology group phase II study.
- How Well does the New Lung Cancer Staging System Predict for Local/Regional Recurrence After Surgery?: A Comparison of the TNM 6 and 7 Systems.
- Weekly Paclitaxel and Carboplatin inDuction chemotherapy followed by concurrent chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck.
- Local recurrence after surgery for early stage lung Cancer: an 11-year experience with 975 patients.
- Image-guided percutaneous thermal ablation for the palliative treatment of chest wall masses.
- Phase I study of the farnesyltransferase inhibitor lonafarnib with weekly paclitaxel in patients with solid Tumors.
- Percutaneous image-guided thermal ablation and radiation therapy: outcomes of combined treatment for 41 patients with inoperable stage I/II non-small-cell lung Cancer.
- Surgical resection is necessary to maximize tumor control in function-preserving, aggressive chemoradiation protocols for advanced squamous Cancer of the head and neck...
- Defaulting patterns in a provincial leprosy control programme in Northern Mozambique.
- Preoperative paclitaxel, carboplatin, and radiation therapy in advanced head and neck Cancer (stage III and IV).
- Chemoradiotherapy for advanced inoperable head and neck Cancer: A phase II study.
- Post transfusion non-cardiogenic pulmonary edema in a patient with chemotherapy-related hemolytic uremic Syndrome.
- Concurrent paclitaxel, carboplatin, and radiotherapy in advanced head and neck Cancers: a phase II study--preliminary results.
- Preoperative chemoradiation coupled with aggressive resection as needed ensures near total control in advanced head and neck Cancer.
- P-selectin induces the expression of tissue factor on monocytes.
- Structural and functional development of cricket ring muscles.
- Development of fast singing muscles in a katydid.
- Treatment choices in chronic myelogenous leukemia.
- Management of unresectable non-small cell Carcinoma of the lung (NSCLC).
- Radiofrequency ablation followed by conventional radiotherapy for medically inoperable stage I non-small cell lung Cancer.
- A low rate of central Nervous system progression in a phase II trial of outpatient chemobiologic therapy with cisplatin, temozolomide, interleukin-2, and interferon al...
- Inhibition of the epidermal growth factor receptor in combined modality treatment for locally advanced non-small cell lung Cancer.
- Gefitinib therapy for non-small cell lung Cancer.
- Consensus report IASLC workshop Bruges, September 2002: pretreatment minimal staging for non-small cell lung Cancer.
- Adjuvant high-dose interferon therapy for high-risk Melanoma.
- Induction or consolidation systemic therapy in the multimodality treatment of unresectable locally advanced non-small cell lung Cancer.
- Update in non-small cell lung Cancer.
- Phase II trial of weekly paclitaxel and gemcitabine for previously untreated, stage IIIB-IV nonsmall cell lung Cancer.
- Concurrent chemoradiotherapy with weekly paclitaxel and carboplatin for locally advanced head and neck Cancer: Long-term follow-up of a Brown University Oncology Group...
- A multi-center phase II study of weekly topotecan as second-line therapy for small cell lung Cancer.
- Preoperative chemotherapy versus preoperative chemoradiotherapy for stage III (N2) non-small-cell lung Cancer.
- Phase I and pharmacokinetic study of gimatecan given orally once a week for 3 of 4 weeks in patients with advanced solid Tumors.
- Double-blind, placebo-controlled, randomized phase 2 study of the proapoptotic agent AT-101 plus docetaxel, in second-line non-small cell lung Cancer.
- Chemoradiotherapy and gefitinib in stage III non-small cell lung Cancer with epidermal growth factor receptor and KRAS mutation analysis: Cancer and leukemia group B (...
- Carboplatin with weekly docetaxel and ifosfamide in advanced head and neck Cancers: a phase I Brown University Oncology Group dose escalation study (HN-93).
- Cetuximab, paclitaxel, carboplatin, and radiation for head and neck Cancer: a toxicity analysis.
- Langerhans Cell histiocytosis following acute leukemia in an adult.
- Persistent N2 disease after neoadjuvant chemotherapy for non-small-cell lung Cancer.
- Selective organ preservation in operable locally advanced head and neck squamous cell Carcinomas guided by primary site restaging biopsy: long-term results of two sequ...
- Positive Interaction between Prophylactic Cranial Irradiation and Maintenance Sunitinib for Untreated Extensive-Stage Small Cell Lung Cancer Patients After Standard Ch...
Schools
Vanderbilt University
Procedures Preformed
- Thoracentesis
Conditions Treated
- Adrenal Gland Cancer
- Anemia
- Antiphospholipid Syndrome (APS)
- Bile Duct Cancer
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- America's Top Doctors
- CMS Meaningful Use Stage 1 Certification
- America's Top Doctors for Cancer
Education
-
Tufts Medical Center -
Brown University -
Vanderbilt University School of Medicine
Hospital
-
Duke University Hospital
Drug Facts
| NPI NUMBER | 1932156197 | |
| NPPES Provider LastName | READY | |
| NPPES Provider FirstName | NEAL | |
| NPPES Provider ZIPCode | 277042121 | |
| NPPES Provider State | NC | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 235.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 22.0 | |
| Percent Opioid Claims | 9.36 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1932156197 |
| Last Name Of The Provider | READY |
| First Name Of The Provider | NEAL |
| View All |
Similar Doctors
|
|
Dr. Timothy J. Kinsella, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Nathan T. Connell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Aleagia Mercer-Falkoff, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Don S. Dizon, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Francis J. Cummings, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anita S. Kestin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dariusz Stachurski, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kimberly Perez, MD |
|
|
Dr. Ritesh Rathore, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mirela R. Stancu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kalyan C. Mantripragada, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sophia Fircanis, MD
This Doctor is OpenDoctor Recommended.
|